PATENT CLAIM ANALYSIS

Application Number: 16212264
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["548", "475000"]

Abstract:
The present disclosure is directed to novel forms of apremilast and pharmaceutical compositions comprising any of the novel forms of apremilast. Also provided are processes for the preparation of novel forms of apremilast.

Claim (Index 17):
A form of apremilast selected from apremilast formic acid solvate Form J, or anhydrous apremilast Form K that has an X-ray powder diffraction pattern comprising peaks, in terms of 2-theta, at about 11.40 and about 13.66.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 98.0
- Lexical Diversity: 1.52174
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15186687', '15577102', '15308740', '15777427', '13105457']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.689622947360392
- 35 USC 102 Novelty (BERT): 0.5713001106537731
- Combined Prediction Score: 0.6777906636897301
- Mean Citation Score: 295.715904
- Max Citation Score: 464.59442
- Similarity Product: 369.98646889083153

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test